Drug archive
Temozolomide (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Temozolomide (tem-oh-ZOHL-oh-mide) belongs to the general group of medicines known as antineoplastics. It is used to treat a specific type of cancer of the brain in adults whose tumors have returned.
Temozolomide seems to interfere with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by temozolomide, other effects will also occur. Some of these may be serious and must be reported to your doctor.
Before you begin treatment with temozolomide, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
Temozolomide is to be administered only by or under the immediate supervision of your doctor. It is available in the following dosage form:
- Capsules (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Temodar
In Canada -
- Temodal